Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022
View ORCID ProfileFayette Klaassen, View ORCID ProfileMelanie H. Chitwood, View ORCID ProfileTed Cohen, View ORCID ProfileVirginia E. Pitzer, View ORCID ProfileMarcus Russi, View ORCID ProfileNicole A. Swartwood, View ORCID ProfileJoshua A. Salomon, View ORCID ProfileNicolas A. Menzies
doi: https://doi.org/10.1101/2022.11.19.22282525
Fayette Klaassen
1Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA
Melanie H. Chitwood
2Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT
Ted Cohen
2Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT
Virginia E. Pitzer
2Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT
Marcus Russi
2Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT
Nicole A. Swartwood
1Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA
Joshua A. Salomon
3Department of Health Policy, Stanford University School of Medicine, Stanford CA
Nicolas A. Menzies
1Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted November 23, 2022.
Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022
Fayette Klaassen, Melanie H. Chitwood, Ted Cohen, Virginia E. Pitzer, Marcus Russi, Nicole A. Swartwood, Joshua A. Salomon, Nicolas A. Menzies
medRxiv 2022.11.19.22282525; doi: https://doi.org/10.1101/2022.11.19.22282525
Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022
Fayette Klaassen, Melanie H. Chitwood, Ted Cohen, Virginia E. Pitzer, Marcus Russi, Nicole A. Swartwood, Joshua A. Salomon, Nicolas A. Menzies
medRxiv 2022.11.19.22282525; doi: https://doi.org/10.1101/2022.11.19.22282525
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)